Sonnet BioTherapeutics Holdings, Inc. (SONN)
NASDAQ: SONN · Real-Time Price · USD
1.440
+0.010 (0.70%)
Feb 21, 2025, 4:00 PM EST - Market closed

SONN Cash Flow Statement

Millions USD. Fiscal year is Oct - Sep.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2018
Period Ending
Dec '24 Sep '24 Sep '23 Sep '22 Sep '21 Sep '20 2019 - 2018
Net Income
-9.43-7.44-18.83-29.72-24.98-24.27
Upgrade
Depreciation & Amortization
0.090.080.080.090.10.06
Upgrade
Asset Writedown & Restructuring Costs
0.010.010.280.97-6.83
Upgrade
Stock-Based Compensation
0.240.230.250.881.380.37
Upgrade
Other Operating Activities
0.370.37---0.12-
Upgrade
Change in Accounts Payable
-0.120.05-2.630.971.720.17
Upgrade
Change in Unearned Revenue
--0.02-0.15-0.350.020.5
Upgrade
Change in Income Taxes
----0.72--
Upgrade
Change in Other Net Operating Assets
0.41-1.9-0.340.1-0.650.73
Upgrade
Operating Cash Flow
-8.43-8.61-21.34-27.77-22.55-15.61
Upgrade
Capital Expenditures
-----0-0.08
Upgrade
Sale (Purchase) of Intangibles
-0.01-0.01-0.44-0.81--
Upgrade
Investing Cash Flow
-0.01-0.01-0.44-0.81-0-0.08
Upgrade
Short-Term Debt Issued
-----0.11
Upgrade
Long-Term Debt Issued
-----0.12
Upgrade
Total Debt Issued
-----0.24
Upgrade
Short-Term Debt Repaid
---0--0.02-0.11
Upgrade
Total Debt Repaid
---0--0.02-0.11
Upgrade
Net Debt Issued (Repaid)
---0--0.020.13
Upgrade
Issuance of Common Stock
10.756.8821.011.8442.8528.86
Upgrade
Other Financing Activities
-0.47-0.39----5.98
Upgrade
Financing Cash Flow
10.286.4921.014.0142.8323.01
Upgrade
Net Cash Flow
1.84-2.12-0.78-24.5720.277.31
Upgrade
Free Cash Flow
-8.43-8.61-21.34-27.77-22.56-15.69
Upgrade
Free Cash Flow Margin
-842.62%-46213.48%-14439.19%-7936.59%-4663.91%-
Upgrade
Free Cash Flow Per Share
-8.08-13.14-164.47-1125.21--
Upgrade
Levered Free Cash Flow
-7.88-8.93-14.63-18.05-13.13-8.86
Upgrade
Unlevered Free Cash Flow
-7.88-8.93-14.63-18.05-13.13-8.86
Upgrade
Change in Net Working Capital
-0.191.832.76-0.33-1.09-1.67
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.